CRISPR/Cas9 genome editing of CCR5 combined with C46 HIV-1 fusion inhibitor for cellular resistant to R5 and X4 tropic HIV-1. - Khamaikawin, Wannisa; Saisawang, Chonticha; Tassaneetrithep, Boonrat; Bhukhai, Kanit; Phanthong, Phetcharat; Borwornpinyo, Suparerk; Phuphuakrat, Angsana; Pasomsub, Ekawat; Chaisavaneeyakorn, Sujittra; Anurathapan, Usanarat; Apiwattanakul, Nopporn; Hongeng, Suradej (Scientific Reports, 2024)